drugset / Trial / NCT00000317
Early Phase II Trials for Cocaine Medication Development - 1
Phase 2
Completed
31 enrolled
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA) · collabResearch Foundation for Mental Hygiene, Inc. · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to develop models for early Phase II testing of potential medications for cocaine dependence: amoxapine, risperidone and other agents. The study was a controlled pilot trial of risperidone in opiate-dependent patients on methadone maintenance. The study explored whether risperidone reduced cocaine use, cocaine craving, and cocaine subjective effects in patients on methadone maintenance who abused cocaine and whether it had an acceptable side effect profile. This
Timeline
- Start
- 1996-08
- Primary completion
- 1999-07
- Completion
- 1999-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 4 mg | — |